Nureca Limited has informed the Exchange regarding Outcome of Board Meeting held on May 05, 2025.
NURECA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nureca Limited's board approved the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025, with an unmodified opinion from statutory auditors B S R & Co. LLP. The standalone results show a net loss for FY25, while the consolidated results reflect a net profit, indicating subsidiaries contributed positively. The board approved appointing Singhi & Co as the new statutory auditor for five years, replacing B S R & Co. LLP whose term ends at the 9th AGM. The board also in-principle approved the merger of wholly owned subsidiary Nureca Technologies Private Limited into Nureca Limited, with no share issuance and no change in shareholding pattern. Several independent directors and the whole-time director were re-appointed, and the 9th AGM is set for June 16, 2025.
The standalone net loss is a negative signal for shareholders, though consolidated profitability tempers the concern. The proposed merger with the wholly owned subsidiary is an internal simplification with no dilution, while the auditor change is a routine rotation at end of term rather than a mid-year switch. Investors should monitor the FY25 detailed numbers for margin and growth trends.